View More Recent Stories

Jan 8, 2025 04:18PM Vanda Pharmaceuticals' (VNDA) Letter to FDA Commissioner Highlights Faulty Gastroparesis NDA Review

Dec 20, 2024 09:14AM Vanda Pharmaceuticals (VNDA) Granted FDA Orphan Drug Designation for VGT-1849A

Nov 6, 2024 04:06PM Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 7c, updates guidance

Oct 14, 2024 10:57AM Vanda Pharmaceuticals (VNDA) Confirms Receipt of $8/sh Non-Binding Proposal from Cycle Group Holdings

Oct 14, 2024 08:19AM Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals (VNDA) for $8/sh

Sep 19, 2024 08:10AM Vanda Pharmaceuticals (VNDA) Falls 13% After FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis

Sep 19, 2024 08:09AM Vanda Pharmaceuticals (VNDA): FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis

Aug 1, 2024 06:35AM Vanda Pharmaceuticals (VNDA) PT Raised to $13 at Cantor Fitzgerald

Jul 31, 2024 04:04PM Vanda Pharmaceuticals (VNDA) Tops Q2 EPS by 5c, provides guidance

Jul 11, 2024 06:36AM Cantor Fitzgerald Starts Vanda Pharmaceuticals (VNDA) at Overweight

Jul 1, 2024 08:02AM Vanda Pharmaceuticals (VNDA) Reports Federal Court Allowed Vanda's HETLIOZ Patent Lawsuit to Proceed

Jun 13, 2024 10:03AM Vanda Pharmaceuticals (VNDA) Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak

View More Recent Stories